Week of June 16 - 22, 2019
Polatuzumab Vedotin- piiq (Polivy™) is an antibody conjugate medication used in the treatment of some types of lymphoma.
Alpelisib (Piqray®) is a kinase inhibitor used in combination with fulvestrant in the treatment of metastatic or advanced breast cancer with a PIK3CA(phosphatidylinositol 3-kinase) mutation.
Colitis is inflammation of the lungs that can be a side effect of immunotherapy treatment.
Pneumonitis is a possible side effect of immunotherapy treatment.
Guidance systems are used to help locate a mass during surgery for breast cancer.
Erdafitinib is a tyrosine kinase inhibitor, a targeted therapy indicated for the treatment of some locally advanced or metastatic urothelial cancers.
Trastuzumab-dttb (Ontruzant®) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.
In this webinar, Dr. Neil Taunk, MD, MS, Assistant Professor and Chief of Gynecologic Radiation Oncology at Penn Medicine, provides an overview of proton radiation therapy for gynecologic cancers.
Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta™) is a medication used in the treatment of some cases of breast cancer.
This webinar provides an overview of proton therapy to treatment spine tumors.
This section contains articles that explain the different types of blood products, and how and why they are transfused.
Calaspargase pegol-mknl (Asparlas™) is an antineoplastic enzyme used in the treatment of some cases of acute lymphoblastic leukemia.